Short answer
Guardant Health, Inc. (GH) filed an 8-K current report with the SEC on November 3, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Retention signal: founders and Co-CEOs Helmy Eltoukhy and AmirAli Talasaz each received 465,413 target PSUs.
Guardant Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Retention signal: founders and Co-CEOs Helmy Eltoukhy and AmirAli Talasaz each received 465,413 target PSUs
- 100% performance-based awards tied to relative TSR versus S&P 500 over three-year and five-year periods
- 25% of PSUs use the three-year period ending May 31, 2029; 75% use the five-year period ending May 31, 2031
- Payout ranges from 0% below the 40th percentile to 250% at or above the 90th percentile
- One-year and six-month post-vesting holding requirements reinforce long-term alignment, while awards support executive retention and succession continuity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Guardant Health, Inc. 8-K filings
Get the next GH 8-K as it lands
Follow GH for push alerts, or ask the research agent what this filing means.